US Patent 7906291 Method for diagnosing multiple sclerosis
Patent 7906291 was granted and assigned to Glycominds Ltd. on March, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+207 characters)
Article
Patent abstract
Disclosed is a method for diagnosing multiple sclerosis and more particularly to a method for diagnosing multiple sclerosis by measuring levels of antibodies to glycans in a biological sample.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Avinoam Dukler0
Nir Dotan0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07906291 Method for diagnosing multiple sclerosis US Patent 7906291 Method for diagnosing multiple sclerosis
Infobox
Patent Number
079062910
Patent Number
79062910
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079062910
Date of Patent
March 15, 2011
0Patent Application Number
113451900
Date Filed
January 31, 2006
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07906291 Method for diagnosing multiple sclerosis
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07906291
Date of patent
March 15, 2011
Patent application number
11345190
Date Filed
January 31, 2006
Patent primary examiner
Find more entities like US Patent 7906291 Method for diagnosing multiple sclerosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
